Pop the Quark

FRAMINGHAM (01/15/2004) - Andre G. Pernet takes over as president at Quark Biotech Inc., a privately held company pioneering endpoint-driven drug development (ED3), described as a vertically integrated development approach. Pernet is currently the chairman of CURx Pharma Inc.

Join the newsletter!

Error: Please check your email address.
Show Comments